首页 | 本学科首页   官方微博 | 高级检索  
检索        

儿童尘螨过敏性哮喘舌下特异性免疫治疗疗效及安全性研究
引用本文:应小明,陈利中,叶辉,金安.儿童尘螨过敏性哮喘舌下特异性免疫治疗疗效及安全性研究[J].现代实用医学,2011,23(6):616-618,621.
作者姓名:应小明  陈利中  叶辉  金安
作者单位:台州市第一人民医院,浙江省台州,318020
摘    要:目的比较舌下特异性免疫治疗(SLIT)联合吸入糖皮质激素(ICS)与单独ICS治疗儿童尘螨过敏轻、中度哮喘的临床疗效及安全性。方法将40例尘螨过敏的轻、中度哮喘患儿随机分为两组:SLIT组(SLIT联合ICS治疗,20例)和对照组(单独ICS治疗,20例)。两组均完成为期1年的临床观察。比较两组患儿ICS给药总量、哮喘日间和夜间症状评分、皮肤点刺试验、肺功能、血清sIgE和视觉模拟评分(VAS)。结果与对照组相比,SLIT组在1年治疗结束时I,CS给药总量少,SLIT组的日、夜间哮喘症状评分低,肺功能用力呼气中期流速(FEF25%~75%)值高,VAS低,差异均有统计学意义(均〈0.05);皮肤点刺试验计分s、IgE值及1 s用力呼气容积(FEV1)值两组差异无统计学意义(〉0.05)。结论 SLIT联合ICS治疗在改善尘螨致敏哮喘儿童的日、夜间哮喘症状、肺功能及VAS方面的疗效优于单独使用ICS治疗。

关 键 词:哮喘  儿童  尘螨  舌下特异性免疫治疗  安全性

Efficacy and safety of sublingual immunotherapy in children with allergic asthma due to dust mite
YING Xiaoming,CHEN Lizhong,YE Hui,JING An.Efficacy and safety of sublingual immunotherapy in children with allergic asthma due to dust mite[J].Modern Practical Medicine,2011,23(6):616-618,621.
Authors:YING Xiaoming  CHEN Lizhong  YE Hui  JING An
Institution:YING Xiaoming,CHEN Lizhong,YE Hui,JING An.(The First people's Hospital,Taizhou318020,Zhejiang,China)
Abstract:ObjectiveTo compare the efficacy and safety of sublingual immunotherapy(SLIT) combined with inhaled corticosteroids(ICS) to that of ICS alone in children with mild and moderate allergic asthma due to dust mite.MethodsForty children with mild and moderate dust mite allergic asthma were randomly divided into two groups: SLIT group(treated with SLIT+ICS,n=20) and the control group(treated with ICS alone,n=20).All the patients finished one-year clinical observation.The amount of ICS administration,the day and n...
Keywords:Asthma  Child  Dust mite  Sublingual immunotherapy  Safety  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号